Infusion of Human Mesenchymal Stem Cells Improves Regenerative Niche in Thioacetamide-Injured Mouse Liver | Zendy

Y. H. Kao | Zendy; YuChun Lin | Zendy; Po–Huang Lee | Zendy; Chia-Wei Lin | Zendy; PoHan Chen | Zendy; Tzong-Shyuan Tai | Zendy; YoChen Chang | Zendy; Ming-Huei Chou | Zendy; Chih-Yang Chang | Zendy; CheukKwan Sun | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Infusion of Human Mesenchymal Stem Cells Improves Regenerative Niche in Thioacetamide-Injured Mouse Liver

Author(s) -

Y. H. Kao,

YuChun Lin,

Po–Huang Lee,

Chia-Wei Lin,

PoHan Chen,

Tzong-Shyuan Tai,

YoChen Chang,

Ming-Huei Chou,

Chih-Yang Chang,

CheukKwan Sun

Publication year - 2020

Publication title -

tissue engineering and regenerative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.719

H-Index - 23

eISSN - 2212-5469

pISSN - 1738-2696

DOI - 10.1007/s13770-020-00274-4

Subject(s) - mesenchymal stem cell , rhoa , fibronectin , wharton's jelly , cancer research , microbiology and biotechnology , chemistry , stem cell , immunology , extracellular matrix , biology , signal transduction

This study investigated whether xenotransplantation of human Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) reduces thioacetamide (TAA)-induced mouse liver fibrosis and the underlying molecular mechanism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research